(Q43553237)

24 November 2017

title

Bromocriptine-induced dissociation of hyperglycemia and prolactin response to restraint (English)

1 reference

24 November 2017

1 reference

Ribeiro-de-Oliveira A

1

1 reference

24 November 2017

Guerra RM

2

1 reference

24 November 2017

Fóscolo RB

3

1 reference

24 November 2017

Marubayashi U

4

1 reference

24 November 2017

Reis AM

5

1 reference

24 November 2017

Coimbra CC

6

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

Pharmacology, Biochemistry and Behavior

24 November 2017

published in

1 reference

24 November 2017

volume

68

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

229-233

1 reference

Prolactin activates tyrosyl phosphorylation of insulin receptor substrate 1 and phosphatidylinositol-3-OH kinase.

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

D1 and D2 dopamine receptors stimulate hypothalamo-pituitary-adrenal activity in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

GBR12909 stimulates hypothalamo-pituitary-adrenal activity by inhibition of uptake at hypothalamic dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Basal and stress-induced corticosterone secretion is decreased by lesion of mesencephalic dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Direct effects of prolactin on corticosterone release by zona fasciculata-reticularis cells from male rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Bromocriptine (Ergoset) reduces body weight and improves glucose tolerance in obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Bromocriptine inhibits the seasonally occurring obesity, hyperinsulinemia, insulin resistance, and impaired glucose tolerance in the Syrian hamster, Mesocricetus auratus

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Acute restraint stress decreases dopamine synthesis and turnover in the median eminence: a model for the study of the inhibitory neuronal influences on tuberoinfundibular dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Acute restraint stress decreases tuberoinfundibular dopaminergic neuronal activity: evidence for a differential response in male versus female rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Central nervous system mediated inhibition of insulin secretion due to 2-deoxyglucose.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

The physiology and mechanisms of the stress-induced changes in prolactin secretion in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

The contribution of the autonomic nervous system to changes of glucagon and insulin secretion during hypoglycemic stress

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Dynamism of chemoarchitecture in the hypothalamic paraventricular nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Stress-induced secretion of pro-opiomelanocortin-derived peptides in rats: relative importance of the anterior and intermediate pituitary lobes.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Effects of handling or immobilization on plasma levels of 3,4-dihydroxyphenylalanine, catecholamines, and metabolites in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Paraventricular nucleus mediates prolactin secretory responses to restraint stress, ether stress, and 5-hydroxy-L-tryptophan injection in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Involvement of 5-HT3 receptors in the prolactin release induced by immobilization stress in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Central dopaminergic and serotoninergic systems in the regulation of adrenal tyrosine hydroxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Effects of hyperprolactinemia on plasma glucose and prolactin in rats exposed to ether stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Blood glucose and prolactin in hyperprolactinemic rats exposed to restraint and surgical stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Effects of hyperprolactinaemia on glucose tolerance and insulin release in male and female rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Plasma prolactin and glucose alterations induced by surgical stress: a single or dual response?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Divergent prolactin and pituitary-adrenal activity in rats selectively bred for different dopamine responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Glucose concentrations in brain and blood: regulation by dopamine receptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Dopamine agonist-induced hyperglycemia in rats: Structure-activity relationships and mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Management of pituitary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Effect of 2–Deoxy—D—Glucose on Insulin Response to Glucose in Intact and Adrenalectomized Monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Guanethidine blocks the 2-deoxy-D-glucose-induced hypothalamic noradrenergic drive to hyperglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, and -3, their association with p85 phosphatidylinositol 3-kinase (PI3-kinase), and concomitantly PI3-kinase activation via JAK2 kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900453-6

7 January 2021

10.1016/S0091-3057(00)00453-6

Identifiers

DOI

1 reference

24 November 2017

1 reference